ON Semiconductor Corp (NASDAQ:ONNN)’s adjusted earnings totaled $75.2 million, or 17 cents a share, while revenue increased year over year to $706.5 million from $661 million. Analysts polled by Thomson Reuters expected the company to earn 15 cents a share on revenue of $711.67 million. The company issued second-quarter revenue guidance in the range of $738 million to $768 million. ON Semiconductor Corp (NASDAQ:ONNN) stock performance was -5.33% in last session and finished the day at $ 8.88. Traded volume was 23.85 million shares in the last session and the average volume of the stock remained 7.89 million shares. The beta of the stock remained 1.72. ON Semiconductor Corp (NASDAQ:ONNN) insider ownership is 0.80%.
Endocyte, Inc. (NASDAQ:ECYT) fell the most in three years following halt in its ovarian cancer treating drug analysis. The company’s shares fell 63% after its cancer drug’s trail was stopped because of failure to help patients. Endocyte, Inc. (NASDAQ:ECYT) dropped -61.91% percent to $ 17.64 million yesterday on volume of 6.62 million shares. The intra-day range of the stock was $ 6.50 – 7.05. Endocyte, Inc. (NASDAQ:ECYT) has a market capitalization of $ 273.61 million.
Actuate Corp (NASDAQ:BIRT), the leading personalized insights and analytics company, announced that it will have received invitation to be present at the MySQL Meetup, which is to be held at San Francisco on May 14, 2014. The MySQL Meetup is for MySQL users, which the most popular open source RDBMS or relational database management systems. Actuate Corp (NASDAQ:BIRT)’s stock on May 2, 2014 reported a decrease of -27.91% to the closing price of $ 3.96. Its fifty two weeks range is $3.41 – 8.23. The total market capitalization recorded $ 185.60 million. The overall volume in the last trading session was 10.03 million shares. In its share capital, Actuate Corp (NASDAQ:BIRT) has 46.81 million outstanding shares.
Merrimack Pharmaceuticals Inc (NASDAQ:MACK) was a big mover last session, as the company saw its shares surge a whopping 59.2% on the day. This broke the recent trend of the company, as the stock is now trading above the volatile price range of $4.39 to $5.35 in the past one-month time frame. On Friday, shares of Merrimack Pharmaceuticals Inc (NASDAQ:MACK) dropped -8.01%to close the day at $ 6.43. Company return on investment (ROI) is -176.90% and its monthly performance is recorded as 22.71%. Merrimack Pharmaceuticals Inc (NASDAQ:MACK) quarterly revenue growth is 22.48%.